These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 4844368)

  • 1. Renin inhibition by pepstatin in experimental hypertension.
    Schölkens BA; Jung W
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):24-34. PubMed ID: 4844368
    [No Abstract]   [Full Text] [Related]  

  • 2. The inhibition of rat renin in sodium depleted and renal hypertensive rats. Comparison of purified antibodies or Fab fragments against mouse submaxillary renin with SQ 20881, and the effect on blood pressure homeostasis.
    Lykkegård S
    Scand J Urol Nephrol Suppl; 1984; 79():17-22. PubMed ID: 6206557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin--angiotensin antagonists and the regulation of blood pressure.
    Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
    Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide inhibitors of renin in cardiovascular studies.
    Haber E
    Fed Proc; 1983 Dec; 42(15):3155-61. PubMed ID: 6196232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-specific inhibition of pressor agents in vivo by the renin inhibitor pepstatin A.
    Oldham AA; Arnstein MJ; Major JS; Clough DP
    J Hypertens; 1984 Apr; 2(2):157-61. PubMed ID: 6398334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of dog renin activity by pepstatin A.
    Miyazaki M; Komori T; Okunishi H; Toda N
    Jpn Circ J; 1979 Sep; 43(9):818-23. PubMed ID: 501901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of the in vivo action of pepstatin: effects on plasma angiotensin II concentration.
    Lazar J; Oster P; Gross F; Hackenthal E
    Biochem Pharmacol; 1974 Oct; 23(19):2776-8. PubMed ID: 4371322
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of a potent inhibitor of subprimate and primate renins.
    Wood JM; Mah SC; Baum HP; de Gasparo M; Cumin F; Rüeger H; Nussberger J
    J Pharmacol Exp Ther; 1990 May; 253(2):513-7. PubMed ID: 2110974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of labetalol in chronic two-kidney Goldblatt hypertension (2-KGH) in rats.
    Gulati OP; Gulati N
    Arch Int Pharmacodyn Ther; 1980 Feb; 243(2):255-60. PubMed ID: 6990887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin inhibition by pepstatin.
    Miller RP; Poper CH; Wilson CW; DeVito E
    Biochem Pharmacol; 1972 Nov; 21(21):2941-4. PubMed ID: 4567022
    [No Abstract]   [Full Text] [Related]  

  • 11. Soluble pepstatins: a new approach to blockade in vivo of the renin-angiotensin system.
    Evin G; Gardes J; Kreft C; Castro B; Corvol P; Menard J
    Clin Sci Mol Med Suppl; 1978 Dec; 4():167s-169s. PubMed ID: 282046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antihypertensive treatment on systolic blood pressure and renin in experimental hypertension in rats.
    Cangiano JL; Rodríguez-Sargent C; Martínez-Maldonado M
    J Pharmacol Exp Ther; 1979 Feb; 208(2):310-3. PubMed ID: 762665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pepstatin: lack of inhibition of the human renin-angiotensinogen reaction.
    García RL; Croxatto HR; Roblero JS
    Acta Physiol Lat Am; 1974; 24(1):92-3. PubMed ID: 4372859
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of renin as a blood-borne hormone tested by infusion of renin inhibitor (H.77).
    Tree M; Fraser R; Holloway C; Hughes M; Ingram M; Leckie BJ; Lever AF; Morton JJ; Szelke M
    Kidney Int Suppl; 1988 Sep; 25():S33-7. PubMed ID: 3054239
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute hypotensive responses to peptide inhibitors of renin in conscious monkeys: an effect on blood pressure independent of plasma renin inhibition.
    Schaffer LW; Schorn TW; Winquist RJ; Strouse JF; Payne L; Chakravarty PK; de Laszlo SE; tenBroeke J; Veber DF; Greenlee WJ
    J Hypertens; 1990 Mar; 8(3):251-9. PubMed ID: 2159506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of ameroid constrictors in the development of renin-dependent hypertension in dogs.
    Brooks DP; Fredrickson TA
    Lab Anim Sci; 1992 Feb; 42(1):67-9. PubMed ID: 1316513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of a competitive renin inhibitory peptide in humans: evidence for multiple mechanisms of action.
    Zusman RM; Burton J; Christensen D; Nussberger J; Dodds A; Haber E
    Trans Assoc Am Physicians; 1983; 96():365-74. PubMed ID: 6388104
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of the renin-system in normo- and hypertension. Effect of angiotensin-inhibitor (1-sar-8-ala-angiotensin II) on the blood pressure of conscious or anaesthetized normal, nephrectomized and renal hypertensive rats.
    Bing J; Nielsen K
    Acta Pathol Microbiol Scand A; 1973 May; 81(3):254-62. PubMed ID: 4358386
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the renin-angiotensin system in normotensive and hypertensive rats with varying renin status.
    Atkinson J; Boillat N; Essadki A; Lüthi P; Maranda B; Sonnay M
    Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):301-15. PubMed ID: 3555376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.